CSTL
Price
$19.47
Change
-$0.83 (-4.09%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
608.02M
35 days until earnings call
CYBQF
Price
$1.30
Change
+$0.09 (+7.44%)
Updated
Jul 1 closing price
Capitalization
467.65M
Interact to see
Advertisement

CSTL vs CYBQF

Header iconCSTL vs CYBQF Comparison
Open Charts CSTL vs CYBQFBanner chart's image
Castle Biosciences
Price$19.47
Change-$0.83 (-4.09%)
Volume$9.37K
Capitalization608.02M
Cyberdyne
Price$1.30
Change+$0.09 (+7.44%)
Volume$553
Capitalization467.65M
CSTL vs CYBQF Comparison Chart in %
Loading...
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSTL vs. CYBQF commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Buy and CYBQF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (CSTL: $20.30 vs. CYBQF: $1.30)
Brand notoriety: CSTL and CYBQF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 35% vs. CYBQF: 58%
Market capitalization -- CSTL: $608.02M vs. CYBQF: $467.65M
CSTL [@Medical Specialties] is valued at $608.02M. CYBQF’s [@Medical Specialties] market capitalization is $467.65M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 0 FA rating(s) are green whileCYBQF’s FA Score has 0 green FA rating(s).

  • CSTL’s FA Score: 0 green, 5 red.
  • CYBQF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CSTL and CYBQF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 5 TA indicator(s) are bullish while CYBQF’s TA Score has 3 bullish TA indicator(s).

  • CSTL’s TA Score: 5 bullish, 4 bearish.
  • CYBQF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CSTL is a better buy in the short-term than CYBQF.

Price Growth

CSTL (@Medical Specialties) experienced а +2.78% price change this week, while CYBQF (@Medical Specialties) price change was +6.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +8.93%. For the same industry, the average monthly price growth was +3.91%, and the average quarterly price growth was +1.61%.

Reported Earning Dates

CSTL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+8.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSTL($608M) has a higher market cap than CYBQF($468M). CYBQF YTD gains are higher at: 25.604 vs. CSTL (-23.827). CYBQF has higher annual earnings (EBITDA): 855M vs. CSTL (-45.02M). CYBQF has more cash in the bank: 19.5B vs. CSTL (243M). CSTL has less debt than CYBQF: CSTL (15.3M) vs CYBQF (538M). CYBQF has higher revenues than CSTL: CYBQF (3.18B) vs CSTL (220M).
CSTLCYBQFCSTL / CYBQF
Capitalization608M468M130%
EBITDA-45.02M855M-5%
Gain YTD-23.82725.604-93%
P/E RatioN/A454.55-
Revenue220M3.18B7%
Total Cash243M19.5B1%
Total Debt15.3M538M3%
FUNDAMENTALS RATINGS
CSTL vs CYBQF: Fundamental Ratings
CSTL
CYBQF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9095
PRICE GROWTH RATING
1..100
5253
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSTL's Valuation (67) in the null industry is in the same range as CYBQF (99). This means that CSTL’s stock grew similarly to CYBQF’s over the last 12 months.

CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as CYBQF (100). This means that CSTL’s stock grew similarly to CYBQF’s over the last 12 months.

CSTL's SMR Rating (90) in the null industry is in the same range as CYBQF (95). This means that CSTL’s stock grew similarly to CYBQF’s over the last 12 months.

CSTL's Price Growth Rating (52) in the null industry is in the same range as CYBQF (53). This means that CSTL’s stock grew similarly to CYBQF’s over the last 12 months.

CSTL's P/E Growth Rating (100) in the null industry is in the same range as CYBQF (100). This means that CSTL’s stock grew similarly to CYBQF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLCYBQF
RSI
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
53%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
20%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
26%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
22%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
25%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
75%
Aroon
ODDS (%)
Bullish Trend 5 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACSLX93.960.90
+0.97%
American Century Select C
NWAEX17.460.14
+0.81%
Nationwide BNY Mellon Dyn US Core Eagle
GCVTX24.340.15
+0.62%
Goldman Sachs Large Cp Val Insghts Inv
MSAAX19.270.03
+0.16%
Morgan Stanley Inst Passport ovrs eq C
PHSWX10.09N/A
N/A
Parvin Hedged Equity Solari World

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with IMTH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then IMTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
+1.45%
IMTH - CSTL
41%
Loosely correlated
-50.24%
VCYT - CSTL
39%
Loosely correlated
N/A
TCMD - CSTL
37%
Loosely correlated
N/A
RDNT - CSTL
36%
Loosely correlated
+0.99%
GH - CSTL
36%
Loosely correlated
+0.64%
More

CYBQF and

Correlation & Price change

A.I.dvisor tells us that CYBQF and CSTL have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYBQF and CSTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBQF
1D Price
Change %
CYBQF100%
N/A
CSTL - CYBQF
27%
Poorly correlated
+1.45%
CYBQY - CYBQF
7%
Poorly correlated
N/A
CNVVF - CYBQF
6%
Poorly correlated
N/A
CNVVY - CYBQF
3%
Poorly correlated
+3.46%
CHEOY - CYBQF
3%
Poorly correlated
N/A
More